Brief: Sparc And Sun Pharma Enter Into License Agreement For Commercialization Of Phenobarbital
Nov 9 (Reuters) - Sun Pharma Advanced Research Co Ltd
SPRC.NS :
* SPARC AND SUN PHARMA ENTER INTO LICENSE AGREEMENT FOR
COMMERCIALIZATION OF PHENOBARBITAL FOR INJECTION IN US
Source text for Eikon: ID:nBSEbFy8Dp
Further company coverage: SPRC.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sun Pharma Advanced Research
See all newsAdvisory: Alert incorrectly tagged to Sun Pharma Advanced Research withdrawn
Brief: Sun Pharma Advanced Research Appoints Anil Raghavan As MD And CEO Effective August 11
Brief: Sun Pharma Advanced Research Says Ocuvex Therapeutics Gets Complete Response Letter For PDP-716 NDA
India's Sun Pharma Advanced Research jumps after swinging to Q4 profit
Brief: Sun Pharma Advanced Research March-Quarter Consol Profit 17.61 Billion Rupees